Beaubrain Healthcare Co., Ltd. (CEO Kim Jae-hak) announced that it will participate in CES 2024, the world’s largest IT and home appliance exhibition, to be held in Las Vegas, USA in January next year.
Beaubrain Healthcare is a company that has developed various solutions that use artificial intelligence to early predict ‘ATN (Amyloid Beta, Tau, Neurodegeneration)’, a biomarker for dementia diagnosis. Through this, we are expanding our research and development capabilities to provide personalized cognitive training programs (digital therapeutics) for dementia prevention and treatment.
Beaubrain Healthcare aims to implement precision medicine by combining ATN biomarkers and cognitive function data accumulated through the provision of these solutions, and Asia’s highest level of genomic data previously secured. With this, the company emphasized that it wants to shift the current dementia treatment paradigm, which focuses on treatment after onset, to early diagnosis and prevention.
BBA (BeauBrain Amylo), developed as part of this vision, is an AI solution that analyzes brain PET and CT images. It enables analysis of each brain region without a 3D MRI image, and can quantify amyloid in six regions, including the striatum.
In addition, as a Centiloids company, it is possible to standardize different amyloid protein ligands, read disease severity, and predict disease prognosis, making it clearly different from existing products.
‘BBM 2D (BeauBrain Morph 2D)’, which uses 2D MRI images, predicts amyloid and tau accumulation through deep learning, and thereby predicts dementia risk index, prognosis, brain age, etc. It is a diagnostic solution. Brain atrophy can be quantified using AI, while also supporting prediction of the ATN biomarker for dementia.
Beaubrain Healthcare plans to target the global market by introducing two solutions that help with precise early diagnosis of dementia at CES 2024. To this end, the company is currently seeking partners and investors for marketing and sales, as well as assisting in executing regulatory approvals.
An official from Beaubrain Healthcare said, “For a startup that has just passed the one-year anniversary of its founding, we are proud of having created remarkable research and development results,” adding, “We are currently working to obtain K-GMP and K-FDA approval by February of next year. , We plan to conduct market verification with a number of tertiary hospitals that are SMC’s cohort network hospitals. In addition, we will pursue market expansion with global pharmaceutical companies, vendors, and insurance companies,” he said.
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition where you can see the flow of innovative technologies around the world at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi
→ Go to the CES 2024 news special page